Journal watch: Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases

850 567 Shawn Haigh

The Background 2-Deoxy-2-[18F]fluoro-d-glucose positron emission tomography (FDG-PET) is a commonly used method to detect regional reductions in brain glucose uptake typically observed in patients with Alzheimer’s disease (AD) and other…

read more
Brain, Man, Alzheimers

Optimising early diagnosis of Alzheimer’s disease – mission impossible?

1920 1080 Anna Stelling, PhD

Alzheimer’s disease (AD) is a very common malady of the elderly, currently affecting 5.8 million Americans above the age of 65. It accounts for 60–80% of all dementia cases, which…

read more
Brainwork is supported by unrestricted grants from: